Patents by Inventor Kathleen MacPhee

Kathleen MacPhee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170214768
    Abstract: A system for modular content deployment and control includes a client device with input and output devices, and storing: graphical background elements and corresponding background identifiers; graphical foreground elements and corresponding foreground identifiers; and audio elements and corresponding audio identifiers. The client presents, via the output device, a subset of the background elements, foreground elements, and audio elements. The system also includes a server connected to the client and storing: sequential stage records each containing a subset of the background identifiers, foreground identifiers and audio identifiers; a client profile corresponding to the client, containing an identifier of a most recent completed stage, and a performance indicator for the most recent completed stage.
    Type: Application
    Filed: January 21, 2016
    Publication date: July 27, 2017
    Inventors: Jim BARBER, Kathleen MACPHEE
  • Publication number: 20020155519
    Abstract: The present invention reports a newly-identified human blood bacterium (HBB), provides characterization, culturing and diagnostic methodologies therefor and methods for the treatment of pathophysiological states caused by the bacterium. The bacterium is apparently present in the bloodstream of all humans in very low numbers, and appears to be directly or indirectly associated with several diseases such as chronic fatigue syndrome, multiple sclerosis and other “autoimmune” diseases. Also provided are uses of engineered HBB.
    Type: Application
    Filed: June 28, 2001
    Publication date: October 24, 2002
    Applicant: Pathobiotek Diagnostics Inc.
    Inventors: Luther E. Lindner, Kathleen MacPhee
  • Patent number: 6255467
    Abstract: The present invention reports a newly-identified human blood bacterium (HBB), provides characterization, culturing and diagnostic methodologies therefor and methods for the treatment of pathophysiological states caused by the bacterium. The bacterium is apparently present in the bloodstream of all humans in very low numbers, and appears to be directly or indirectly associated with several diseases such as chronic fatigue syndrome, multiple sclerosis and other “autoimmune” diseases. Also provided are uses of engineered HBB.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: July 3, 2001
    Assignee: Pathobiotek Diagnostics Inc.
    Inventors: Luther E. Lindner, Kathleen MacPhee